Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015–2016

Table 4 Association between obstetrical history and uptake of three or doses of IPTp with SP

Characteristic	N^† Total = 1069	% women took 3+ doses		Rao-Scott F-test	p-value
Characteristic	N^† Total = 1069	n^‡ (%)	(95%CI)	Rao-Scott F-test	p-value
Parity
One child	277	125 (45.0)	37.4–52.9	F (3.83, 2158.02) = 2.5382	0.0407*
Two children	244	110 (45.0)	36.6–53.7
Three children	161	79 (48.7)	40.1–57.3
Four children	132	51 (38.6)	29.0–49.3
Five or more children	254	82 (32.4)	26.8–38.6
Timing of 1st ANC visit
1st trimester	222	103 (46.2)	37.6–54.9	F (1.94, 1094.85) = 7.9535	0.0004*
2nd trimester	753	327 (43.5)	39.1–48.0
3rd trimester	94	17 (17.8)	10.5–28.6
Number of ANC visits
4+	500	260 (52.0)	46.2–57.7	F (1.85, 1045.90) = 31.8155	<0.001*
3	413	172 (41.6)	35.7–47.7
1–2	156	15 (9.9)	6.1–15.4

^†weighted total frequency, ^‡weighted frequency of women who took three or more doses of IPTp-SP, *potential candidate for multivariate logistics regression because p < 0.25

ISSN: 1471-2458